scPharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Net Income	-54.81	-36.84	-28.03	-32.21	-33	-29.44	-23.82	-24.38	-10.52
Depreciation & Amortization	0.63	0.47	0.44	0.4	0.36	0.33	0.02	0.01	0
Share-Based Compensation	4.86	2.84	2.37	2	1.45	2.14	0.95	0.88	0.38
Other Operating Activities	-9.92	-1.05	-1.92	2.12	0.74	-1.84	0.17	8.04	0.5
Operating Cash Flow	-59.24	-34.58	-27.15	-27.69	-30.44	-28.81	-22.68	-15.46	-9.64
Capital Expenditures	-0.04	-0.02	-0.01	0	0	0	-0.19	-0.01	-0.02
Change in Investments	20.01	-45.84	32.14	-33.46	0	0	0	0	0
Investing Cash Flow	19.97	-45.86	32.13	-33.46	0	0	-0.19	-0.01	-0.02
Share Issuance / Repurchase	14.85	47.98	0.05	61.31	4.03	0.05	92.81	0	0.02
Debt Issued / Paid	0	29.3	-2.5	-0.8	9.56	-0.06	9.27	12.6	0
Other Financing Activities	-	-0.05	-0.08	-0.16	-	-	-0.01	40.57	7.99
Financing Cash Flow	14.85	77.23	-2.53	60.35	13.59	-0.01	102.07	53.17	8.02
Net Cash Flow	-24.43	-3.21	2.45	-0.81	-16.85	-28.82	79.2	37.71	-1.64
Free Cash Flow	-59.28	-34.6	-27.16	-27.69	-30.44	-28.81	-22.88	-15.46	-9.66
Free Cash Flow Margin	-436.14%	-	-	-	-	-	-	-	-
Free Cash Flow Per Share	-1.54	-1.22	-0.99	-1.13	-1.64	-1.55	-7.72	-15.87	-12.65

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).